$SUPN SUPERNUS PHARMACEUTICALS, INC. Insider Trading
Get free email notifications about insider trading in SUPERNUS PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in SUPERNUS PHARMACEUTICALS, INC.. Insider overview, share value development, latest insider transactions and email notifications about new events in SUPERNUS PHARMACEUTICALS, INC. for free.
CIK Number: 0001356576
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: SUPN
Company Address: 9715 KEY WEST AVENUE ROCKVILLE 20850
Phone number: 301-838-2500
Former name: SUPERNUS PHARMACEUTICALS INC, date of change: 2006-03-17
Market Capitalization: $1.26B
Prev close: $24.65
Average Daily Volume: 529,453
Days Low: $24.05
Year Low: $11.98
Year High: $27.95
SUPERNUS PHARMACEUTICALS, INC. Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 14 2021 | SUPN | SUPERNUS PHARMACEU ... | Martin Tami Tillotson | Sr. V.P., Regulator ... | Option Exercise | M | 12.98 | 3,125 | 40,563 | 6,250 | |
Apr 14 2021 | SUPN | SUPERNUS PHARMACEU ... | Martin Tami Tillotson | Sr. V.P., Regulator ... | Option Exercise | M | 12.98 | 3,125 | 40,563 | 9,375 | |
Apr 14 2021 | SUPN | SUPERNUS PHARMACEU ... | Martin Tami Tillotson | Sr. V.P., Regulator ... | Sell | S | 31.98 | 3,125 | 99,938 | 86,326 | 89.5 K to 86.3 K (-3.49 %) |
Apr 14 2021 | SUPN | SUPERNUS PHARMACEU ... | Martin Tami Tillotson | Sr. V.P., Regulator ... | Buy | M | 12.98 | 3,125 | 40,563 | 89,451 | 86.3 K to 89.5 K (+3.62 %) |
Apr 14 2021 | SUPN | SUPERNUS PHARMACEU ... | Martin Tami Tillotson | Sr. V.P., Regulator ... | Sell | S | 29.98 | 3,125 | 93,702 | 86,326 | 89.5 K to 86.3 K (-3.49 %) |
Apr 14 2021 | SUPN | SUPERNUS PHARMACEU ... | Martin Tami Tillotson | Sr. V.P., Regulator ... | Buy | M | 12.98 | 3,125 | 40,563 | 89,451 | 86.3 K to 89.5 K (+3.62 %) |
Mar 30 2021 | SUPN | SUPERNUS PHARMACEU ... | Khattar Jack A. | President, CEO | Sell | J | 0.00 | 10,000 | 0 | 1,058,450 | 1.1 M to 1.1 M (-0.94 %) |
Mar 30 2021 | SUPN | SUPERNUS PHARMACEU ... | Khattar Jack A. | President, CEO | Buy | J | 0.00 | 10,000 | 0 | 516,466 | 506.5 K to 516.5 K (+1.97 %) |
Feb 23 2021 | SUPN | SUPERNUS PHARMACEU ... | Kelly James Patrick | Executive Vice-Pres ... | Option Exercise | A | 29.61 | 15,000 | 444,150 | 15,000 | |
Feb 23 2021 | SUPN | SUPERNUS PHARMACEU ... | Rubin Jonathan | SVP, Chief Medical ... | Option Exercise | A | 29.61 | 25,000 | 740,250 | 25,000 | |
Feb 23 2021 | SUPN | SUPERNUS PHARMACEU ... | Martin Tami Tillotson | Sr. V.P., Regulator ... | Option Exercise | A | 29.61 | 17,000 | 503,370 | 17,000 | |
Feb 23 2021 | SUPN | SUPERNUS PHARMACEU ... | Mottola Frank | SVP, Quality, GMP O ... | Option Exercise | A | 29.61 | 17,000 | 503,370 | 17,000 | |
Feb 23 2021 | SUPN | SUPERNUS PHARMACEU ... | Bhatt Padmanabh P. | Sr. VP of IP, CSO | Option Exercise | A | 29.61 | 17,000 | 503,370 | 17,000 | |
Feb 23 2021 | SUPN | SUPERNUS PHARMACEU ... | Khattar Jack A. | President, CEO | Option Exercise | A | 29.61 | 200,000 | 5,922,000 | 200,000 | |
Dec 22 2020 | SUPN | SUPERNUS PHARMACEU ... | Schwabe Stefan K.F. | Executive Vice Pres ... | Option Exercise | M | 12.98 | 46,347 | 601,584 | 0 |
View all SUPERNUS PHARMACEUTICALS, INC. insider transactions.